Nomura maintained a buy rating on Torrent Pharma but raised the target to Rs 2199 from Rs 1838 earlier. The potential acquisition of Cipla will be a big deal and it makes strategic sense. The acquisition will require large debt and equity dilution.
J Infratech files IPO papers; eyes Rs 600 cr via fresh issue
J Infratech Ltd has submitted preliminary papers for an initial public offering valued at Rs 600 crore. The IPO includes a fresh issue and an